Diametrics purchases Pfizer unit for $8.7 million
This article was originally published in Clinica
Executive Summary
Diametrics Medical, a US developer of point-of-care blood analysis systems, has purchased Biomedical Sensors from US healthcare group Pfizer for $1.5 million in cash and a $7.3 million, six-year promissory note. Biomedical Sensors is based in High Wycombe, UK, and markets a line of monitoring systems for continuous blood and tissue assessment of critically ill patients.